This list is an analysis based on recent market events. It's not an investment recommendation.
About
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers Empliq Dermal, an acellular dermal matrix (ADM) sourced from donated human skin and designed to replace lost or damaged dermal tissue; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
The current price of RNV.AU is A$0.09 AUD — it has decreased by -1.12% in the past 24 hours. Watch Renerve stock price performance more closely on the chart.
What is Renerve stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Renerve stocks are traded under the ticker RNV.AU.
Is Renerve stock price growing?▼
RNV.AU stock has fallen by -4.35% compared to the previous week, the month change is a +4.76% rise, over the last year Renerve has showed a -12% decrease.
What is Renerve market cap?▼
Today Renerve has the market capitalization of 15.16M
What is Renerve revenue for the last year?▼
Renerve revenue for the last year amounts to 272,000 AUD.
What is Renerve net income for the last year?▼
RNV.AU net income for the last year is -3.73M AUD.